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Abstract
The peptidoglycan of Staphylococcus aureus is characterized by a high degree of crosslinking and almost completely lacks
free carboxyl groups, due to amidation of the D-glutamic acid in the stem peptide. Amidation of peptidoglycan has been
proposed to play a decisive role in polymerization of cell wall building blocks, correlating with the crosslinking of
neighboring peptidoglycan stem peptides. Mutants with a reduced degree of amidation are less viable and show increased
susceptibility to methicillin. We identified the enzymes catalyzing the formation of D-glutamine in position 2 of the stem
peptide. We provide biochemical evidence that the reaction is catalyzed by a glutamine amidotransferase-like protein and a
Mur ligase homologue, encoded by SA1707 and SA1708, respectively. Both proteins, for which we propose the designation
GatD and MurT, are required for amidation and appear to form a physically stable bi-enzyme complex. To investigate the
reaction in vitro we purified recombinant GatD and MurT His-tag fusion proteins and their potential substrates, i.e. UDP-
MurNAc-pentapeptide, as well as the membrane-bound cell wall precursors lipid I, lipid II and lipid II-Gly5. In vitro amidation
occurred with all bactoprenol-bound intermediates, suggesting that in vivo lipid II and/or lipid II-Gly5 may be substrates for
GatD/MurT. Inactivation of the GatD active site abolished lipid II amidation. Both, murT and gatD are organized in an operon
and are essential genes of S. aureus. BLAST analysis revealed the presence of homologous transcriptional units in a number
of gram-positive pathogens, e.g. Mycobacterium tuberculosis, Streptococcus pneumonia and Clostridium perfringens, all
known to have a D-iso-glutamine containing PG. A less negatively charged PG reduces susceptibility towards defensins and
may play a general role in innate immune signaling.
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Introduction
In gram-positive bacteria a thick multilayered peptidoglycan
(PG) constitutes the major component of the cell wall and is
essential for survival, maintenance of cell shape and counterbal-
ance of turgor pressure [1]. The heteropolymer consists of
alternating disaccharide units composed of N-acetyl-glucosamine
(GlcNAc) and N-acetyl-muramic acid (MurNAc), that are cross-
linked by short peptides to form a rigid network.
The biosynthesis of PG is a multistep process which requires
numerous enzymatic reactions, occurring in three compartments
of a bacterial cell; the cytoplasm (synthesis of nucleotide-bound
precursors), the inner face of the membrane (synthesis of the cell
wall building block lipid II and lipid II modifications) and the outer
face of the membrane (polymerisation of lipid II into the growing
PG network). Biosynthesis starts in the cytoplasm, where the
MurA-F ligases catalyze the formation of the ultimate soluble cell
wall precursor UDP-MurNAc-pentapeptide [2–5]. In the follow-
ing membrane associated step, UDP-N-acetyl-muramic acid-
pentapeptide is linked to the membrane carrier undecaprenol
-phosphate (C55-P) by the translocase MraY, resulting in the
formation of lipid I (undecaprenylphosphate-MurNAc-pentapep-
tide). MurG subsequently links UDP-GlcNAc to the N-acetyl-
muramic acid moiety of lipid I, yielding lipid II (undecaprenylpho-
sphate-GlcNAc-MurNAc-pentapeptide) [3,6,7]. In Staphylococcus
aureus this central cell wall building block is further modified by the
addition of a pentaglycine interpeptide bridge, catalyzed by the
FemXAB peptidyltransferases [8–12]. The modified lipid II is then
translocated across the cytoplasmic membrane engaging FtsW
flippase activity [13] and assembled into the growing PG network,
through the activity of penicillin binding proteins (PBPs) by
transglycosylation and transpeptidation reactions [14–16]. Fol-
lowing synthesis and assembly the S. aureus PG undergoes further
modifications including O-acetylation of N-acetyl-muramic acid
[17–19] and the addition of structures that are covalently linked,
such as wall teichoic acids [20], proteins and capsules [21,22].
Apart from this, the PG of staphylococci almost completely lacks
free carboxyl groups, since the a-carboxyl group of D-glutamic acid
at position 2 of the stem peptide is amidated, resulting in the
formation of D-iso-glutamine [23]. Using a cell-free system with
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26crude membrane preparations Siewert and Strominger (1968)
suggested that the lipid bound precursors could serve as acceptors of
ammonia in an ATP-dependent reaction [24].
Until now the primary role of D-Glu amidation of the stem
peptide has remained elusive and the enzyme catalyzing the
amidation reaction has not been identified so far.
Extensive genetic analysis and characterization of mutant cell
walls revealed several loci in the genome of S. aureus affecting the
degree of muropeptide amidation [25,26]. A femC (factor essential
for methicillin resistance) mutant was described exhibiting 48%
decreased muropeptide amidation [27], accompanied by a
reduction in methicillin resistance. The femC phenotype resulted
from the disruption of the glutamine synthetase repressor glnR
causing a polar effect on glutamine synthetase (GlnA) expression,
whichinturnledtoa drasticreductionofthe intracellularglutamine
pool [27]. Together with the observation that the external addition
of glutamine to the medium restored the femC defect [28], this
could suggest that glutamine may be a nitrogen donor.
On the functional level D-Glu amidation appears to be relevant
for efficient transpeptidation of neighboring stem peptides. A
considerable reduction of PG crosslinking was observed in the femC
mutant accompanied by a high percentage of free D-Ala-D-Ala
termini [11,29], suggesting that non-amidated cell wall precursors
are imperfect substrates for one or more transpeptidases. In
accordance, it has been shown early by Nakel et al. that
crosslinking of two adjacent stem peptides requires at least one
of the stem peptides involved to be amidated [30]. Characteris-
tically, the PG of S. aureus is extensively crosslinked, with up to
95% of the stem peptides interconnected [31]. The coordinated
crosslinking therefore plays a decisive role for S. aureus survival; its
perturbation appears to impair growth and to cause aberrant
septum formation and severe cell deformation. Interestingly,
FemC is essential for the full expression of methicillin resistance
in methicillin-resistant S. aureus (MRSA), as also observed with
femXAB mutants which are defective in pentaglycine bridge
formation [32].
In this study, we identified the enzymes catalyzing stem peptide
amidation. We found the glutamine amidotransferase-like protein
SA1707 (designated GatD; UniProtKB: Q7A4R4) in concert with
the Mur ligase homologue SA1708 (designated MurT; Uni-
ProtKB: Q7A4R3) to catalyze the amidation of the a-carboxyl
group of D-glutamic acid of cell wall precursor stem peptides.
Characterization of these enzymes and in vitro reconstitution of
their amidation reaction will enable detailed analysis of their
functional role on transpeptidation and translocation of cell wall
precursors as well as provide new opportunities to identify selective
antibiotic inhibitors of these essential proteins.
Materials and Methods
Strains
S. aureus COL and S. aureus RN4220 were maintained on blood
or Luria Bertani (LB) broth (Oxoid). S. aureus strains carrying
antisense plasmids (kindly provided by Merck) were maintained on
LB-agar plates supplemented with 34 mg/ml chloramphenicol
[33,34]. E. coli BL21 was used for overexpression of recombinant
His6-tag fusion proteins and maintained on LB-agar plates
containing 50 mg/ml ampicillin.
RNA interference and antibiotic susceptibility testing
MRSA COL (MB 5393) was transformed with antisense
interference plasmids correspond to SA1707 (SAV1891), SA1708
(SAV1892) or vector control as previously described [35]. Assay
plates were prepared by seeding 10
7 cells/ml of each culture into
48uC cooled LB Miller agar containing 34 mg/ml chloramphen-
icol with or without 50 mM xylose. Agar plates were allowed to set
and then spotted with 10 ml of each drug as previously described
[36] and incubated at 37uC with humidity for 18 hours. Plectasin
was tested at increasing amounts ranging from 0.5 to 10 mg and
spotted in 10 ml aliquots each.
Cloning, overexpression and purification of S. aureus
murT, gatD and glnA as His6-tag fusions
S. aureus N315 murT (SA1708), gatD (SA1707) and glnA were
amplified using forward and reverse primers as listed in Table 1
and cloned into a pET21b vector (Novagen) using NdeI and
XhoI restriction sites to generate C-terminal His6-fusion proteins.
E. coli BL21(DE3) (Promega) cells transformed with the approp-
riate recombinant plasmid were grown in LB-medium (50 mg/ml
ampicillin) at 37uC. At an OD600 of 0.6, IPTG was added at a
concentration of 0.75 mM to induce expression of the recombi-
nant proteins. After 4 h, cells were harvested and resuspended in
lysis buffer (50 mM Tris/HCl, pH 7.5, 300 mM NaCl, 10 mM
imidazole). Aliquots of 200 mg/ml lysozyme, 100 mg/ml DNase
and 10 mg/ml RNase were added; cells were incubated for
30 min on ice and sonicated. Cell debris was spun down. The
supernatant was applied to Ni-NTA- (Qiagen) or Talon-
(Clontech) agarose slurry. This mixture was gently stirred at
4uC for 2 h and then loaded onto a column support. After
washing with lysis buffer, weakly bound material was removed
with 50 mM Tris/HCl, pH 7.5, 300 mM NaCl and 20 mM
imidazole. His-tagged recombinant proteins eluted with buffer
containing 50 mM Tris/HCl, pH 7.5, 300 mM NaCl and 100–
200 mM imidazole. Three fractions were collected each and were
stored in 30% glycerol at 220uC. Purity was controlled by SDS-
Page.
Co-purification of the GatD/MurT enzyme complex
The gatD/murT operon was amplified using primers murT-for
and gatD-rev (Table 1) and cloned into pET21b vector (Novagen)
generating a C-terminal gatD-His tag fusion. The corresponding
plasmid was introduced into E. coli BL21 (Promega) and
overexpression was carried out as described above. Co-elution
from Ni-NTA column (Qiagen) of the GatD-His6/MurT complex
was analyzed by SDS page.
Author Summary
The bacterial peptidoglycan is a hetero-polymer, consist-
ing of sugars and amino acids, that forms a stress-bearing
sacculus around bacterial cells and provides cell shape. The
cell envelope and its components represent a central
interface for interactions with the environment and are
therefore subject to species-specific modifications. The
peptidoglycan of many Gram positive pathogens such as
Staphylococcus aureus is almost fully amidated which
appears to reduce the susceptibility towards innate host
defenses. Here, we describe the so far elusive enzymes that
catalyze the amidation of the peptidoglycan precursors
and provide biochemical evidence for acceptor and
nitrogen donor substrates. We show that two enzymes
are necessary to catalyze the amidation and that both
enzymes form a stable heterodimer complex. Besides
substantial progress in understanding of peptidoglycan
biosynthesis our results provide the molecular basis for
screening for mechanistically novel antibiotics.
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active site
Site directed mutagenesis of GatD catalytical triad/active site
was carried out using the QuikChange Lightning Mutagenesis
Kit (Stratagene) following the instructions of the manufacturer
using plasmid pET21-gatD as the template. Mutagenesis primers
(GatD_mut1; GatD_mut2) are listed in Table 1, resulting in
exchange of Cys (TGT).Gly (GGA; 348). The GatD_mut(C94G)
protein has been purified as described above.
Synthesis of [
14C]-UDP-MurNAc-pentapeptide by purified
S. aureus MurA-F and DdlA enzymes
[
14C]-N-acetyl muramic acid pentapeptide (UDP-MurNAc-pp)
was synthesized on the basis of the protocol described by Wong
et al. elaborated for E. coli [37] with modifications [38]. In short,
100 nmol UDP-GlcNAc were incubated in the presence of 2 mg
MurA-F and DdlA protein each in 50 mM Tris-Bis-propane,
pH 8, 25 mM (NH4)2SO4, 5 mM MgCl2, 5 mM KCl, 0.5 mM
DTT, 2 mM ATP, 2 mM PEP, 2 mM NADPH, 1 mM of each
amino acid (L-Lys, D-Glu, L-Ala, D-Ala, respectively) and 10%
DMSO in a total volume of 125 ml for 90 min at 30uC. If not
mentioned elsewhere the radiolabel was introduced using [
14C]-L-
lysine. Purification was performed as described [39].
In vitro lipid I synthesis reaction using purified MraY
Lipid I-synthesis was carried out in a total volume of 60 ml
containing 2.5 nmol C55-P, 25 nmol of UDP-MurNAc-pp in
100 mM Tris-HCl, 30 mM MgCl2, pH 7.5, and 10 mM N-
lauroyl sarcosine. The reaction was initiated by the addition of
7.5 mg of the enzyme and incubated for 90 min at 30uC.
Synthesized lipid I was extracted from the reaction mixture with
n-butanol/pyridine acetate, pH 4.2 (1:1; v/v) and purification and
quantification was carried out as described for lipid II [12]. [
14C]-
labeled lipid I was synthesized in the presence of 25 nmol [
14C]-
UDP-MurNAc-pentapeptide.
In vitro lipid II and lipid II-Gly5 synthesis and purification
Synthesis and purification of lipid II was performed using
membranes of Micrococcus luteus as described [40–42]. In short,
membrane preparations (200 mg protein) were incubated in the
presence of purified substrates, 5 nmol undecaprenylphosphate
(C55-P), 50 nmol UDP-MurNAc-pp and 50 nmol [
14C]-UDP-
GlcNAc in 60 mM Tris-HCl, 5 mM MgCl2, pH 7.5, and 0.5%
(w/v) Triton X-100 in a total volume of 50 ml for 1 h at 30uC.
Bactoprenol containing products were extracted with the same
volume of butanol/pyridine acetate (2:1; vol:vol; pH 4.2) and
analyzed by TLC using phosphomolybdic acid (PMA) staining.
For synthesis of mg-quantities of lipid II the analytical assay was
scaled up and purification was performed as described [12]. Lipid
II-Gly5 was synthesized using purified lipid II, purified recombi-
nant FemXAB peptidyltransferases, tRNA and Glycyl-tRNA-
synthetase as described previously [12]. Purification was per-
formed as described for lipid II.
In vitro synthesis of amidated lipid intermediates
The assays for synthesis of amidated lipid intermediates were
performed in a total volume of 30 ml containing 2 mg of purified
MurT-His6 and GatD-His6. If not indicated elsewhere, 2 nmol of
purified lipid intermediates, lipid I and lipid II, respectively were
incubated in 160 mM Tris-HCl, 0.7% Triton X-100, 5 mM KCl,
40 mM MgCl2, pH 7.5, 6 mM ATP and 7 mM glutamine for 2 h
at 30Cu. Synthesis products were extracted from the reaction
mixture with the same volume of n-butanol/pyridine acetate,
pH 4.2, and analyzed by TLC solvent B (butanol, acetic acid,
water, pyridine, 15:3:12:10). Radiolabeled spots or lanes were
visualized using a storage phosphor screen in a Storm imaging
system (GE Healthcare). Non-radiolabeled lipid intermediates
were analyzed using PMA staining. Isolation of larger quantities
of non-radioactive-labeled amidated lipid II intermediates was
achieved with an upscale of the synthesis assay and subsequent
purification via preparative TLC. To this end, lipid spots were
visualized using iodine vapor and material was scratched of the
silica plates. Lipids were extracted by incubation in 100 mlo f
chloroform/methanol (1:1; v/v) for 60 min.
Mass spectrometry
Electrospray MS spectra were recorded on a micrOTOF-Q
quadrupole-TOF instrument (Bruker) working in negative mode.
Samples were infused at 0.2–3 ml h-1, either directly (in methanol–
chloroform, 1:1) or diluted 1:1 in methanol. The spectra were
externally calibrated with sodium formiate in methanol.
Results
Set up of the detection system for amidated lipid II
S. aureus membrane preparations possessing the enzymatic
activity of MraY and MurG synthesize cell wall precursors
lipid I and lipid II, respectively [43]. Furthermore Siewert and
Strominger showed that after addition of ATP, NH4Cl or
glutamine, amidated lipid I or lipid II can be detected in such
membranes [24]. We used purified lipid II together with S. aureus
membranes, glutamine and ATP and observed an additional lipid
II band, distinguished by an elevated Rf-value (Figure 1, lane 2).
When glutamine and ATP were omitted from the reaction
mixture, predominantly unmodified lipid II was detected (Figure 1,
lane 3); marginal conversion to the newly formed lipid II (lane 3)
might result from traces of residual ATP and glutamine in the
membrane preparation. Therefore, lipid II appears to be a direct
substrate for this modification, as initially proposed [24]. The
newly formed modified lipid II was analyzed by ESI-TOF-MS
running in negative mode (Figure 2). A mass decrease of 1 (0.5 for
the doubly charged ion) is consistent with amidation of the a-
carboxyl-OH group (Figure 2). The altered migration behavior of
amidated lipid II in the TLC-system provided a convenient and
robust assay for further analysis of the amidation reaction.
In vitro activity of MurT and GatD
Recently, a large-scale antisense interference-based phenotypic
screen was performed to identify genes required for the broad b-
Table 1. Primers used in this study.
Primer Sequence (59-39)
a
murT-for GCGCGCATATGAGACAGTGGACGGCAAT
murT-rev GCGCGCTCGAGTGATTGACCTCCTTCAAACGA
gatD-for CGCGCGCATATGCATGAATTGACTATTTATCTAAAAT
gatD-rev GCGCGCTCGAGACGAGATTTCTTCTGTCTATTTG
glnA-for GATTTTCATATGCCAAAACGTACT
glnA-rev TGTTTAGCCTCGAGATATTGCT
gatD_mut1
b GGATTAACAATTGGAGGAGGCTATCAATTTTTA
gatD_mut2
b TAAAAATTGATAGCCTCCTCCAATTGTTAATCCCGG
a- restriction sites are underlined.
b- nucleotide exchange in bold.
doi:10.1371/journal.ppat.1002509.t001
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cus aureus (MRSA) [36]. Two yet uncharacterized open reading
frames identified in this analysis correspond to SA1707 and
SA1708. Upon antisense-mediated depletion in expression of
SA1707 and SA1708, MRSA strain COL displayed prominently
restored susceptibility to diverse carbapenem and cephalosporin b-
lactam antibiotics (Figure S1). Moreover depletion resulted in
increased susceptibility to plectasin (Figure S2), a defensin known
to inhibit cell wall biosynthesis through specific binding of lipid II
[44]. SA1707 encodes a putative glutamine amidotransferase with
homology to cobyric acid synthases, whereas the co-transcribed
SA1708 gene (Figure S3 A) encodes an uncharacterized protein
with homology to the Mur-ligases MurE and F, involved in
pentapeptide side chain assembly during peptidoglycan synthesis.
Progressive reduction of SA1707 and SA1708 expression through
increasing xylose concentrations impaired the growth rate,
strongly suggesting that both genes are essential for S. aureus
viability (Figure S4). Nevertheless morphology of partially GatD/
MurT depleted cells was unaltered, as revealed by electron
microscopy (data not shown). BLAST analysis revealed the
presence of an equivalent gene arrangement in a number of
gram-positive bacteria, such as M. tuberculosis, S. pneumonia and C.
perfringens (Figure S3 B). Interestingly, only bacteria which are
reported to contain an amidated PG [23], encode homologues of
SA1707 and SA1708, suggesting their potential functional role in
PG amidation (Figure S3). Accordingly, based on sequence
similarities to glutamine amidotransferases (GATases) and Mur
ligases, as well as in vitro biochemical evidence (see below), we
propose to designate SA1707 and SA1708 as GatD and MurT,
respectively.
To investigate GatD and MurT function both proteins were
purified as His-tag fusion proteins (purity .95%) and an
individual in vitro assay was set up based on the information
obtained using membrane preparations (Figure 3A). As revealed
by TLC, neither MurT, nor GatD alone were sufficient to catalyze
the amidation of lipid II when added separately to the reaction
Figure 1. Migration behavior of lipid II and amidated lipid II on
thin layer chromatography (TLC). TLC of lipid II incubated in the
absence (lane 1) and presence (lane 2) of S. aureus membrane prepara-
tions. Only when supplemented with ATP and glutamine (lane 2), a
modified lipid II was separated. Omission of glutamine and ATP almost
completely abolished synthesis of the lipid II variant (lane 3).
doi:10.1371/journal.ppat.1002509.g001
Figure 2. Mass spectrometry of non-amidated and amidated Lipid II. ESI-MS spectra were obtained with a micrOTOF-Q instrument running
in negative mode. Peaks at m/z 936.52 correspond to lipid II (A) and at m/z 936.02 to amidated lipid II (B) for the doubly charged molecules,
corresponding to a neutral mass of 1875 and 1874, respectively.
doi:10.1371/journal.ppat.1002509.g002
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observed compared to the negative control (lane 1). However co-
addition of GatD and MurT to the assay (2 mg each) resulted in
complete conversion of lipid II to an amidated lipid II species (lane
2). Omission of glutamine from the reaction mixture resulted in no
formation of amidated lipid II (lane 5), further providing evidence
for glutamine to be a direct nitrogen donor for cell wall precursor
amidation. Monitoring the reaction over time showed a maximum
glutamine-dependent conversion to the reaction product after
incubation for 2 h (Figure 3B) with a pH optimum of 7.5–7.8. At
pH 5.5 GatD/MurT were completely inactive (data not shown).
Lipid II amidation is dependent on the concerted activity
of MurT and GatD
To investigate the co-requirement of GatD and MurT for lipid
II amidation, MurT was individually substituted by S. aureus Mur-
ligases MurC-F in the synthesis assay, as exemplarily shown with
MurE (Figure 4 A). However, in spite of sharing sequence identity
of up to 23% with S. aureus Mur ligases, MurT functional activity
could not be replaced in the in vitro lipid II amidation assay using
purified MurC, D, E and F proteins. Interestingly, MurT could
substitute for MurE activity in vitro, resulting in the formation of
UDP-MurNAc-(Ala-Glu-Lys)-tripeptide (data not shown). Despite
these results, however, it appears unlikely that S. aureus MurT is
able to substitute for MurE in vivo, since murT or murE are each
essential (unlike for example the non-essential murA, murZ paralogs)
[45–48]. Further a murE-transposon mutant with reduced specific
activity was shown to accumulate UDP-MurNAc-dipeptide in the
cytoplasm [49,50].
Incubation of increasing concentrations of MurT (0–2 mg) in
the presence of 2 mg GatD (Figure 4 B; squares) further
substantiated the interdependency of both proteins. Increasing
MurT concentrations led to enhanced amidation of lipid II with
a maximum activity observed at 1.5 mg of MurT, which
corresponds to a molar ratio of MurT:GatD of 1:1 (molecular
masses of 49.2 kD for MurT and 27.4 kD for GatD), suggesting
the formation of a heteromeric complex by the two proteins. We
then co-expressed both genes with a His-tag attached only to the
C-terminus of GatD. The Ni-NTA column eluate contained
both enzymes in similar amounts (Figure S5), strongly suggesting
that in vivo both enzymes form a physically stable bi-enzyme
complex.
Inactivation of the GatD active site
Analysis of sequence similarity identified GatD as a member of
the superfamily of glutamine amidotransferases (GATases). These
enzymes catalyze the transfer of an amide nitrogen from glutamine
to its substrate to form a new carbon-nitrogen group [51]. Until
now 16 glutamine amidotransferases have been identified, which
are grouped into two classes: class-I (also referred to as trpG-type)
and class-II (also known as purF-type) [52]. GATases possess two
functional domains; a glutaminase- and a synthase- domain, which
Figure 3. In vitro activity of MurT and GatD. (A) Purified recombinant GatD and MurT enzymes were incubated with purified lipid II. In the
negative control (lane 1) the reaction was immediately stopped by the addition of BuOH/Pyr/Ac. Time dependency of the GatD/MurT catalyzed
reaction. (B) Purified [
14C]-lipid II was incubated in the presence of 2 mg MurT and GatD each, glutamine and ATP. The reaction was stopped by the
addition of BuOH/PyrAc and the amount of amidated lipid II was quantified using phosphoimaging; mean values of three independent experiments
are given.
doi:10.1371/journal.ppat.1002509.g003
Figure 4. Amidation of the cell wall precursor lipid II in vitro. (A) Amidation is catalyzed by the cooperative action of GatD and MurT (lane 1)
and MurT cannot be replaced by MurE ligase (lane 2) or any other Mur-ligase (not shown). Interdependency of GatD/MurT. (B) Increasing
concentrations of purified GatD (dots) or MurT (squares) proteins (0–2 mg) were incubated in the presence of glutamine, ATP and [
14C]-lipid II in the
presence of a fixed concentration of 2 mg MurT and GatD, respectively. A maximum conversion to amidated lipid II was observed only at equimolar
ratio, considering the molecular masses of 49.2 kD (MurT) and 29.7 kD (GatD).
doi:10.1371/journal.ppat.1002509.g004
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which form a heterodimeric GATase complex [51,52].
The 243 amino acid GatD protein specifically shares sequence
similarities with glutaminase domains of class I-type GATases, that
hydrolyse glutamine to generate glutamate and ammonia (NH3)
[53]. S. aureus GatD shares the conserved cysteine and histidine
residues of class I-type GATases. In the bacterial enzymes
described here the third catalytical triad residue glutamine is
missing, however a glycine residue appears highly conserved
(Figure 5 B). Within the active site the cysteine is essential for
glutaminase activity [52–54], since its nucleophilic sulfhydryl side
chain initiates the amide transfer through the formation of a
thioester with the substrate glutamine [55].
To explore the functional role of catalytical triad, site-directed
mutagenesis of S. aureus GatD was performed by replacing the
canonical cysteine of the proposed active site (position 94) with
glycine (Figure 5 B). Unlike wild type GatD (Figure 5 A, lane 2),
amidation of lipid II was not observed using the GatD_C94G
protein. The inability of the GatD mutant to use glutamine
provides further evidence for the function of GatD as a
glutaminase and confirms the active site of the enzyme. Consistent
with these findings, the catalytical triad active site and structural
features of S. aureus GatD appear broadly conserved amongst
gram-positive bacteria, including M. tuberculosis, C. perfringens and S.
pyogenes (Figure 5 B).
Substrate specificity – acceptor substrate and stage of
amidation
As GatD and MurT enzymes catalyze the amidation of lipid II
(Figure 3), we further included purified lipid I and lipid II-Gly5 in
the in vitro assay, in attempt to narrow down the primary acceptor
substrate and stage of amidation. Amidation analysis revealed that
both lipid intermediates, lipid I and lipid II-Gly5, also serve as a
substrate (Figure 6) and complete conversion to the amidated lipid
variant was found when incubated in the presence of ATP and
glutamine. Conversely, addition of purified UDP-MurNAc-
pentapeptide at 10-fold molar excess with respect to lipid II
present in the synthesis assay, had only a minor impact on the
formation of amidated lipid II; no influence on lipid II amidation
was observed upon UDP-MurNAc-pentapeptide addition reduced
at 5-fold molar excess (Figure 6). These data support the
conclusion that amidation exclusively occurs at the stage of
bactoprenol-bound cell wall precursors. To investigate the
possibility of a concerted activity with the MurC-F enzymes of S.
aureus during stem peptide formation, we incubated MurT and
GatD in the presence of purified MurA-F enzymes, UDP-GlcNAc,
ATP and glutamine. Following inactivation of these enzymes, the
reaction products were incubated with C55-P and MraY for
another 60 minutes and reaction products were analyzed by TLC.
As shown in Figure 6 B no change in the migration behavior was
observed when MurA-F enzymes were incubated in the presence
of GatD/MurT (lane 4), compared to the control where GatD/
MurT were omitted and lipid I was formed. Moreover, either in
the presence (lane 4) or absence of glutamine (lane 5), only the
formation of unmodified lipid I was detected, suggesting that
amidation does not occur during MurC-F catalyzed stem peptide
formation and that the soluble cell wall precursor UDP-MurNAc-
pentapeptide does not serve as a substrate for the amidation
reaction. Moreover, these results are in good agreement with the
fact that only non-amidated UDP-MurNAc-pentapeptide was
isolated from the cytoplasm of S. aureus and from other staphy-
lococcal strains used in this study to purify UDP-MurNAc-
pentapeptide, as analyzed by mass spectrometry (data not shown).
Substrate specificity – nitrogen donor
To investigate the donor substrates of GatD/MurT, the in vitro
assay was supplemented with various potential nitrogen donors. As
summarized in Table 2, GatD/MurT exclusively utilize glutamine
as the nitrogen donor at neutral pH and neither ammonia nor
NH4Cl were found to be substrates. Conversely, in combination
with purified glutamine synthase GlnA, amidation was observed in
the presence of glutamate and NH4Cl, resulting from the GlnA
catalyzed conversion of glutamate and NH4Cl to glutamine, the
latter of which then serves as a substrate for GatD/MurT. In
contrast, at pH 8.5 where the concentration of unprotonated
ammonia is higher, NH3-dependent activity of GatD/MurT was
also observed in vitro, a finding that has been reported earlier for
other GATases [56]. Interestingly, with the GatD_C94G mutant
enzyme NH3-dependent activity of MurT was unaffected, while a
complete loss of glutamine-dependent activity was observed,
suggesting different binding sites for glutamine and NH3 on the
Figure 5. Inactivation of the GatD active site disrupts enzyme activity. (A) Sequence alignment of GatD homologues from selected bacterial
species. (B) The catalytical triad C-H-G (boxed) is highly conserved in these species. In the S. aureus GatD mutant (GatD_C94G) cysteine in position 94
has been mutated to glycine, resulting in inactivation of the active site (A).
doi:10.1371/journal.ppat.1002509.g005
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catalyze the amidation of lipid II independently, irrespective of the
pH or the nature of the nitrogen donor, further demonstrating that
the concerted action of GatD/MurT is a prerequisite for
amidotransferase activity.
Discussion
Cell wall biosynthesis is a vital and highly dynamic process for
almost all bacteria requiring continuous biosynthesis and mainte-
nance involving species-specific modifications. Among these
modifications the amidation of the peptidoglycan (PG) constitutes
a relatively minor biochemical variation, but is of central
importance for S. aureus viability. Until now the primary role of
the amidation of D-glutamic acid in position 2 of the stem peptide
has remained elusive and an enzyme catalyzing the reaction has
not been identified so far. In this study we identified GatD
(SA1707) and MurT (SA1708) as the enzymes catalyzing the
amidation of the S. aureus peptidoglycan building block. In vitro
analysis using purified proteins and substrates demonstrated that
amidation is catalyzed by a glutamine amidotransferase bi-enzyme
complex encoded by two so far uncharacterized open reading
frames SA1707 (GatD) and SA1708 (MurT).
Glutamine amidotransferases (GATases) in general are involved
in a variety of cellular processes like synthesis of amino acids,
nucleotides, amino sugars, and antibiotics [51]. Characteristically
GATases are composed of two different catalytic domains, each
contributing to the catalysis of a single biochemical reaction;
hydrolysis of glutamine (glutaminase domain) and the transfer of
reducednitrogentoitsspecificacceptorsubstrate(synthasedomain).
Both reactions are tightly coupled and require the close interaction
of both folding domains, that can either derive from a single
polypeptide, from two distinct polypeptides or more infrequently
derive from different enzymes which then form a heterodimeric
GATase [52 and references therein], as demonstrated here for
GatD (glutaminase) and MurT (ATP-dependent synthetase).
Most GATases have been reported to use both glutamine and
NH3 as a nitrogen donor and to contain two corresponding
nitrogen substrate binding sites, a glutamine- and an ammonia-
dependent binding site [52]. This is in line with our finding that at
pH 8.5, where the concentration of unprotonated ammonia is
higher, free ammonia also served as a substrate for the GatD/
MurT catalyzed reaction in vitro. In contrast to the glutamine-
dependent activity, which was abolished by a glycine substitution
in place of the catalytical cysteine residue, the ammonia-
dependent amidation of lipid II was unaffected when MurT was
incubated in the presence of the GatD_C94G enzyme.
Although the enzymatic function of the glutaminase domain is
dispensable when NH3 is used as nitrogen donor at pH 8.5, the
interaction of MurT with its cognate glutaminase domain appears
to be crucial for the overall GATase activity. Several conforma-
tional changes have been reported to occur upon domain assembly
to form the active enzyme for a number of different GATases
from several organisms [57–59]. As shown for glutamine synthase
GlmS, specific residues belonging to the synthase domain
participate in the glutaminase site and thereby contribute to the
coupling of the active sites of both domains [60]. As further
observed by structural analysis, most GATases shuttle ammonia
through a solvent-inaccessible channel from the glutaminase-active
site to the synthase-active site [57,61], to prevent NH3 release and
the formation of non-reactive ammonium ions as well as toxic side
effects within the cell. These ammonia channels are predominantly
formed by the synthase domain and its formation has been shown
to also require the presence of the acceptor substrate in most
GATases [57,61]. Moreover, both glutaminase- and synthase-
activities are only optimal in the presence of nitrogen donor and
Figure 6. Acceptor substrate specificity of the GatD/MurT catalyzed reaction. (A) Radiolabeled lipid I, lipid II and lipid II-Gly5 were incubated
together with glutamine and ATP in the presence (gray bars) and absence (white bars) of GatD/MurT. The addition of a 5- and 10-fold molar excess of
UDP-MurNAc-pentapeptide (black bars) only resulted in minor reduction of amidated lipid II synthesized. Amidation is not catalyzed in concert
with MurA-F. (B) Purified MurA-F enzymes were incubated in the presence and absence of GatD/MurT enzymes. After incubation the reaction
product was added to a MraY-catalyzed lipid I synthesis assay using C55-P. No change in migration behavior of the respective lipid I reaction products
was observed.
doi:10.1371/journal.ppat.1002509.g006
Table 2. Substrate specificity of MurT/GatD.
substrates
glutamine NH3 NH4Cl glutamate/NH4Cl
enzymes pH 7.5
MurT/GatD + 22 2
MurT/GatD_C94G 22 2 2
GlnA+MurT/GatD + 22 +
pH 8.5
MurT/GatD ++ + nd*
MurT/GatD_C94G 2 ++ nd*
*nd; not determined.
MurT/GatD and MurT/GatD_C94G catalyzed amidation of lipid II was analyzed in
the presence of diverse putative nitrogen donor substrates at pH 7.5 and
pH 8.5, respectively.
doi:10.1371/journal.ppat.1002509.t002
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interdomain signaling mechanism might ensure regular substrate
binding and consumption. Likewise synchronization might promote
the efficiency of the reaction that with regard to the essentiality of
the acceptor substrate lipid II, needs to be highly coordinated to
allow for a proper processing of cell wall biosynthesis.
The amidation reaction appears highly specific for glutamine
and no other nitrogen donor was accepted by GatD/MurT except
for ammonia at elevated pH. Considering the neutral pH within
the cytoplasm and the fact that in a FemC mutant, incapable of
synthesizing glutamine, the amidation of PG is dramatically
reduced, it is most likely that in vivo glutamine serves as the
nitrogen donor for GatD/MurT.
In contrast to the glutaminase domain of GATases, which are
highly homologous throughout the entire GAT-family, the syn-
thase domains differ largely as to the different acceptor substrates
used and the different underlying biochemical reactions catalyzed
[52]. MurT shares sequence similarity with the Mur-ligase MurE.
Mur-ligases (C-F) catalyze the sequential assembly of the
pentapeptide side chain of the soluble cell wall precursor UDP-
MurNAc-pentapeptide. Mechanistically, these reactions proceed
via the formation of an acyl phosphate intermediate by pho-
sphorylation of the respective C-terminal carboxylate of the UDP-
activated sugar at the expense of one molecule of ATP [62].
As shown for various GATases the amidation reaction itself is
independent of ATP hydrolysis, while for a subgroup of enzymes
the ATP-dependent activation of the acceptor substrate has been
described [52]. The GatD/MurT catalyzed reaction is ATP- and
Mg
2+-dependent, strongly suggesting the formation of an activated
acceptor intermediate prior to amidation, in which the phosphate
group is then displaced by the incoming nitrogen group. This is
further supported by the observation that MurT was able to
substitute MurE in an in vitro UDP-MurNAc-pentapeptide syn-
thesis assay, assuming the capability to bind L-lysine, UDP-
MurNAc-dipeptide and to activate the D-Glu carboxylate by
phosphorylation.
As deduced from a sequence alignment with MurE ligase,
MurT exhibits the ATP consensus binding site GTNGKT and a
short sequence (DNAADD) with similarity to the L-Lys binding
site (DNPAND) present in MurE [63,64]. Nevertheless, since
MurE and MurT are both essential, MurT appears unable to
normally substitute for MurE function in vivo.
Despite the ability of MurT to functionally substitute for MurE-
dependent stem peptide synthesis in vitro, we propose MurT-
catalyzed amidation likely occurs at the stage of bactoprenol-
bound cell wall precursors, prior to their export to the outside and
subsequent polymerization into the growing PG network (Figure 7).
This is based on the observation that lipid I, lipid II, and lipid II-
Gly5 are all amidated in a GatD/MurT dependent manner,
whereas UDP-MurNAc-pentapeptide, did not interfere with the
GatD/MurT catalyzed amidation reaction. However, as all lipid
intermediates were found to serve as a substrate for GatD/MurT
in vitro to the same extent under the conditions chosen, additional
experiments are required to further elucidate the sequence of the
reaction in vivo.
Recently MraY and MurG have been reported to form a
complex [65,66], suggesting a sterically unfavorable situation for
the amidation of lipid I. Further, in the protist Cyanophora paradoxa
modification of the D-Glu of the stem peptide with putrescine has
also been reported to occur at a membrane-bound stage of
peptidoglycan biosynthesis and appeared to be more efficient with
lipid II as a substrate [67]. Considering that GatD/MurT are
Figure 7. Model for the GatD/MurT-catalyzed amidation during cell wall biosynthesis in S. aureus. The GatD/MurT bi-enzyme complex
uses glutamine as the primary nitrogen donor and ammonia is shuttled from the GatD glutaminase active site to the MurT synthetase active-site.
MurT finally catalyzes the amidation in an ATP-dependent fashion to the acceptor substrate which could be lipid II or, as depicted here, lipid II-Gly5.
doi:10.1371/journal.ppat.1002509.g007
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occurs after lipid II or lipid II-Gly5 is formed (Figure 7).
Functionally, amidation could facilitate the translocation of the
cell wall building block lipid II across the cytoplasmic membrane
as a consequence of the reduction of polarity. Amidation actually
may provide a signal for lipid II translocation, which would then
suggest that lipid II-Gly5 serves in vivo as the acceptor, as depicted
in the proposed model (Figure 7).
Crosslinking of two adjacent stem peptides via the characteristic
pentaglycin-interpeptide bridge requires at least one of the stem
peptidesinvolvedtobeamidated [30],suggestingthat non-amidated
lipidIIisaninefficientsubstrateforoneormoretranspeptidasesinS.
aureus. This critical role for PG precursor amidation and reduced
resistance of MRSA femC mutants to methicillin is also consistent
with the broad b-lactam hypersusceptibility phenotypes of GatD
and MurT antisense depletion strains we observed (Figure S1).
Considering that PG precursor translocation, transglycosyla-
tion, and transpeptidation reactions are tightly interlinked, GatD/
MurT dependent amidation may function to coordinate these
biochemical events within this macromolecular heteromeric
complex. For example, synthetically generated amidated mur-
opeptides have recently been shown to be preferred substrates for
the Ser/Thr kinase PknB in M. tuberculosis compared to their non-
amidated counterparts [68]. Interestingly, the extracytoplasmic
part of the membrane anchored PknB protein comprises repeating
units of PASTA domains (penicillin binding protein and Ser/Thr
kinase associated), predicted to bind to the D-Ala-D-Ala terminus
of PG precursors [69], thus emphasizing the potential relationship
between amidation and transpeptidation. Amidation may also
constitute a checkpoint for PknB dependent PG turnover, cell
growth and cell division. Interestingly, like GatD and MurT, PknB
antisense depletion strains were also identified to display
dramatically restored b-lactam susceptibility phenotypes among
MRSA isolates, emphasizing their common participation in PG
biosynthesis and cell wall biogenesis.
Since amidation of D-Glu also results in a less negatively
charged PG, reduction of susceptibility towards innate defense
mechanisms, provided by cationic molecules such as defensins and
lysozym is very likely. In line with this, we observed increased
efficacy of plectasin against GatD/MurT depleted cells. Plectasin
has been shown to specifically bind to lipid II and its N-terminal
amino group is supposed to contribute to binding through
interaction with the carboxyl group of the D-Glu residue [44].
Considering the essentiality of these proteins in S. aureus (Figure
S4) [46–48], M. tuberculosis [70] and S. pneumoniae [71], their broad
conservation across gram-positive bacterial pathogens, and the
development of robust in vitro assays for PG amidation described
here, identifying inhibitors to these targets offers a new approach
to developing both monotherapeutics as well as combination
agents to pair with existing b-lactam antibiotics, thereby restoring
their activity against MRSA.
Supporting Information
Figure S1 b-lactam hypersusceptibility phenotypes of
gatD (SA1707) and murT (SA1708) versus murE by
antisense depletion in MRSA strain COL. (A) Antisense
bearing strains were seeded in LB agar plates supplemented with
50 mM xylose to partially repress gene expression (top row) or
without xylose (bottom row) as negative control for antisense-
specific hypersusceptibility phenotypes. MurE depletion has
independently been demonstrated in COL to yield strong b-
lactam hypersusceptibility phenotypes when placed under the
control of an IPTG regulatable promoter [46] and serves as an
additional control for the antisense-specific phenotypes described
here. Antibiotics tested include imipenem (IPM), ertapenem
(ERT), cefepime (CEF), ceftazidime (CEFTRA), ceftriaxome
(CEFTRI), pipercillin/tazobactam (PIP-TAZ), and vancomycin
(VAN). (B) Alignment of distinct antisense interference fragments
map within SA1707 (SAV1891) and SA1708 (SAV1892) open
reading frames. The gatD antisense interference fragment maps to
nucleotide position 198 to 336, relative to the ATG start codon of
the open reading frame (139 bp in length). The murT antisense
interference fragment encompases both murT and gatD; starting at
nucleotide position 1112 of murT open reading frame and ends at
nucleotide position 43 of gatD open reading frame (331 bp in
length).
(TIF)
Figure S2 Impact of murT-gatD depletion on defensin
susceptibility. Plectasin (0–10 mg) was spotted onto LB agar
plates supplemented with 50 mM xylose seeded with antisense
bearing strains, AS-MurT_GatD and AS_vector control, respec-
tively.
(TIF)
Figure S3 murT-gatD transcriptional unit as predicted
by VIMSS. (A) MurT-GatD homologues found in species known
to contain amidated PG. (B)
(TIF)
Figure S4 Antisense Mediated Essentiality of murE-AS,
gatD-AS and murT-AS by xylose induction. Antisense
bearing strains were seeded in LB agar plates. Various levels of
xylose were spotted on the plates (25 mmol to 0.8 mmol). The
vector-AS strain serves as negative control for xylose induced
antisense-specific hypersusceptibility phenotypes.
(TIF)
Figure S5 Analysis of the GatD/MurT heteromeric bi-
enzyme complex formation. The gatD/murT operon was co-
expressed in E. coli with a His6-tag solely attached to gatD. Co-
elution of both proteins from a Ni
2+-NTA column revealed
complex formation after SDS page analysis. E1–E5, elution
fractions 1–5; M, protein marker (Fermentas, page ruler).
(TIF)
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